+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Difluprednate"

From
From
Uveitis Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Uveitis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 204 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Difluprednate is a topical corticosteroid used to treat a variety of skin conditions, including eczema, psoriasis, and dermatitis. It is available in both ointment and cream forms, and is typically applied twice daily. Difluprednate is a potent corticosteroid, meaning it is more effective than other topical corticosteroids, but also carries a higher risk of side effects. The Difluprednate market is composed of a variety of pharmaceutical companies that produce and distribute the drug. These companies include major pharmaceutical companies such as GlaxoSmithKline, Merck, and Pfizer, as well as smaller companies such as Galderma and Taro Pharmaceuticals. The Difluprednate market is highly competitive, with companies competing for market share and pricing. Companies must also ensure that their products meet the highest standards of safety and efficacy. As such, companies must invest heavily in research and development in order to remain competitive. Show Less Read more